Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-03-03 Sale |
2025-03-04 4:10 pm |
AGIOS PHARMACEUTICALS INC. | AGIO | Goff Brian Chief Executive Officer |
12,947 | $35.54 | $460,136 | 318,345 (Direct) |
View |
| 2024-08-08 Sale |
2024-08-12 5:15 pm |
AGIOS PHARMACEUTICALS INC. | AGIO | Goff Brian Chief Executive Officer |
11,091 | $42.75 | $474,140 | 101,483 (Direct) |
View |
| 2024-06-05 Sale |
2024-06-07 4:25 pm |
AGIOS PHARMACEUTICALS INC. | AGIO | Goff Brian Chief Executive Officer |
12,115 | $48.84 | $591,697 | 143,775 (Direct) |
View |
| 2024-03-05 Sale |
2024-03-05 4:10 pm |
AGIOS PHARMACEUTICALS INC. | AGIO | Goff Brian Chief Executive Officer |
4,156 | $32.57 | $135,361 | 320,280 (Direct) |
View |
| 2024-01-24 Sale |
2024-01-24 4:20 pm |
AGIOS PHARMACEUTICALS INC. | AGIO | Goff Brian Chief Executive Officer |
7,635 | $21.64 | $165,221 | 151,546 (Direct) |
View |
| 2024-01-09 Sale |
2024-01-09 4:28 pm |
AGIOS PHARMACEUTICALS INC. | AGIO | Goff Brian Chief Executive Officer |
12,066 | $22.99 | $277,397 | 159,181 (Direct) |
View |
| 2023-08-08 Sale |
2023-08-10 4:07 pm |
AGIOS PHARMACEUTICALS INC. | AGIO | Goff Brian Chief Executive Officer |
10,178 | $25.48 | $259,335 | 71,974 (Direct) |
View |
| 2023-06-30 Sale |
2023-06-30 4:05 pm |
AGIOS PHARMACEUTICALS INC. | AGIO | Goff Brian Chief Executive Officer |
11,449 | $28.36 | $324,694 | 158,734 (Direct) |
View |
| 2021-07-21 Sale |
2021-07-23 4:42 pm |
ALEXION PHARMACEUTICALS INC. | ALXN | Goff Brian EVP & Chief Commercial Officer |
150,832 | $0 | $0 | 0 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-03-01 Exercise |
2025-03-04 4:10 pm |
N/A N/A |
AGIOS PHARMACEUTICALS INC. | AGIO | Goff Brian Chief Executive Officer |
26,500 | $0 | 318,345 (Direct) |
View |
| 2025-03-01 Option Award |
2025-03-04 4:10 pm |
N/A N/A |
AGIOS PHARMACEUTICALS INC. | AGIO | Goff Brian Chief Executive Officer |
181,500 | $0 | 318,345 (Direct) |
View |
| 2024-08-08 Exercise |
2024-08-12 5:15 pm |
N/A N/A |
AGIOS PHARMACEUTICALS INC. | AGIO | Goff Brian Chief Executive Officer |
22,691 | $0 | 101,483 (Direct) |
View |
| 2024-06-13 Option Award |
2024-06-17 5:14 pm |
N/A 2034-06-12 |
Intellia Therapeutics Inc. | NTLA | Goff Brian Director |
37,706 | $0 | 37,706 (Direct) |
View |
| 2024-06-05 Exercise |
2024-06-07 4:25 pm |
N/A N/A |
AGIOS PHARMACEUTICALS INC. | AGIO | Goff Brian Chief Executive Officer |
25,527 | $0 | 143,775 (Direct) |
View |
| 2024-03-01 Exercise |
2024-03-05 4:10 pm |
N/A N/A |
AGIOS PHARMACEUTICALS INC. | AGIO | Goff Brian Chief Executive Officer |
8,500 | $0 | 320,280 (Direct) |
View |
| 2024-03-01 Option Award |
2024-03-05 4:10 pm |
N/A N/A |
AGIOS PHARMACEUTICALS INC. | AGIO | Goff Brian Chief Executive Officer |
249,500 | $0 | 320,280 (Direct) |
View |
| 2024-01-20 Exercise |
2024-01-24 4:20 pm |
N/A N/A |
AGIOS PHARMACEUTICALS INC. | AGIO | Goff Brian Chief Executive Officer |
17,018 | $0 | 151,546 (Direct) |
View |
| 2024-01-05 Exercise |
2024-01-09 4:28 pm |
N/A N/A |
AGIOS PHARMACEUTICALS INC. | AGIO | Goff Brian Chief Executive Officer |
25,527 | $0 | 159,181 (Direct) |
View |
| 2023-08-08 Exercise |
2023-08-10 4:07 pm |
N/A N/A |
AGIOS PHARMACEUTICALS INC. | AGIO | Goff Brian Chief Executive Officer |
22,691 | $0 | 71,974 (Direct) |
View |
| 2023-06-28 Exercise |
2023-06-30 4:05 pm |
N/A N/A |
AGIOS PHARMACEUTICALS INC. | AGIO | Goff Brian Chief Executive Officer |
25,528 | $0 | 158,734 (Direct) |
View |
| 2023-03-01 Option Award |
2023-03-03 4:06 pm |
N/A N/A |
AGIOS PHARMACEUTICALS INC. | AGIO | Goff Brian Chief Executive Officer |
120,000 | $0 | 120,000 (Direct) |
View |
| 2022-08-08 Option Award |
2022-08-09 4:50 pm |
N/A 2032-08-08 |
AGIOS PHARMACEUTICALS INC. | AGIO | Goff Brian Chief Executive Officer |
629,156 | $0 | 629,156 (Direct) |
View |
| 2021-07-14 Option Award |
2021-07-16 4:43 pm |
N/A N/A |
ALEXION PHARMACEUTICALS INC. | ALXN | Goff Brian EVP & Chief Commercial Officer |
60,144 | $0 | 150,832 (Direct) |
View |
| 2021-06-08 Tax Withholding |
2021-06-09 4:52 pm |
N/A N/A |
ALEXION PHARMACEUTICALS INC. | ALXN | Goff Brian EVP & Chief Commercial Officer |
1,086 | $177 | 90,688 (Direct) |
View |
| 2021-02-28 Option Award |
2021-03-02 5:55 pm |
N/A N/A |
ALEXION PHARMACEUTICALS INC. | ALXN | Goff Brian EVP & Chief Commercial Officer |
24,473 | $0 | 91,774 (Direct) |
View |
| 2020-12-16 Tax Withholding |
2020-12-18 5:09 pm |
N/A N/A |
ALEXION PHARMACEUTICALS INC. | ALXN | Goff Brian EVP & Chief Commercial Officer |
21,395 | $157.96 | 67,301 (Direct) |
View |
| 2020-12-16 Option Award |
2020-12-18 5:09 pm |
N/A N/A |
ALEXION PHARMACEUTICALS INC. | ALXN | Goff Brian EVP & Chief Commercial Officer |
40,677 | $0 | 67,301 (Direct) |
View |
| 2020-06-08 Tax Withholding |
2020-06-09 4:58 pm |
N/A N/A |
ALEXION PHARMACEUTICALS INC. | ALXN | Goff Brian EVP & Chief Commercial Officer |
1,642 | $114.61 | 48,019 (Direct) |
View |